In direct comparisons, semaglutide at higher doses consistently outperforms dulaglutide for weight outcomes
A commonly used protocol involves administration five times per week for approximately eight weeks, followed by a two-week break before repeating the cycle, if appropriate
but other options include skin care, common illnesses, heart health, primary care, and more
it belongs to the Gentianaceae family
Rybelsus gained momentum in 2020 and increased every year thereafter, constituting the third most common brand in 2023, whereas Trulicity started to increase in 2023
Liraglutide is effective for weight loss and blood sugar control, but is less potent than newer GLP-1 medications such as semaglutide (Ozempic, Wegovy, and Rybelsus) and tirzepatide (Mounjaro and Zepbound), which provide greater weight loss and better sugar control